@xconomy.com 3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@techcrunch.com 7 years ago
CRISPR pioneer Jennifer Doudna shines hope on the future of genetic modification at SXSW